Form 4: DocGo Inc. Director Stephen K. Klasko Receives Stock Options

Stephen K. Klasko, a director at DocGo Inc., was granted options to purchase 204,082 shares of common stock.

Summary

• Stephen K. Klasko, a director of DocGo Inc., received options to purchase 204,082 shares of the company's common stock.
• The options were granted under the DocGo Inc. 2021 Stock Incentive Plan.
• The exercise price of the options is $4.16 per share.
• The options will vest and become exercisable on the first anniversary of the grant date, which is November 12, 2024.
• The options expire on November 12, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard practice of granting stock options to a director, which is generally viewed positively as it aligns interests. There are no negative implications.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting period encourages long-term commitment from the director.

Future Outlook

The options will vest and become exercisable on the first anniversary of the grant date, subject to the terms of the Plan.

Industry Context

Stock option grants are a common practice for incentivizing directors and aligning their interests with shareholders in publicly traded companies.

Comparison to Industry Standards

• Stock option grants are a standard form of compensation for directors in publicly traded companies.
• The vesting period of one year is typical for such grants, aligning with industry norms.
• The exercise price of $4.16 is set at the market price at the time of the grant.

Stakeholder Impact

• The stock option grant may positively impact shareholder value if the director's performance leads to company growth.

Key Dates

Keywords

stock options, insider trading, stock incentive plan, director, equity, DocGo Inc., DCGO